Pharmacologically controlling protein-protein interactions through epichaperomes for therapeutic vulnerability in cancer
Ontology highlight
ABSTRACT: Cancer cell plasticity due to the dynamic architecture of interactome networks provides a
vexing outlet for therapy evasion. Here, through chemical biology approaches for systems
level exploration of protein connectivity changes applied to pancreatic cancer cell lines,
patient biospecimens, and cell- and patient-derived xenografts in mice, we demonstrate
interactomes can be re-engineered for vulnerability. By manipulating epichaperomes phar-
macologically, we control and anticipate how thousands of proteins interact in real-time
within tumours. Further, we can essentially force tumours into interactome hyperconnectivity
and maximal protein-protein interaction capacity, a state whereby no rebound pathways can
be deployed and where alternative signalling is supressed. This approach therefore primes
interactomes to enhance vulnerability and improve treatment efficacy, enabling therapeutics
with traditionally poor performance to become highly efficacious. These findings provide
proof-of-principle for a paradigm to overcome drug resistance through pharmacologic
manipulation of proteome-wide protein-protein interaction networks..
INSTRUMENT(S): Q Exactive HF
ORGANISM(S): Homo Sapiens (ncbitaxon:9606)
SUBMITTER: Thomas A. Neubert
PROVIDER: MSV000085630 | MassIVE | Thu Jun 25 13:18:00 BST 2020
REPOSITORIES: MassIVE
ACCESS DATA